YARW
Yarrow Bioscience Inc
24.00$
-6.0%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | 79.0% | 6.6% | – | – | – | – | 4.0% | |
| – | 100.0% | 100.0% | 100.0% | 21.0% | 93.4% | 100.0% | 100.0% | 100.0% | 100.0% | 96.0% | |
| – | 1,669.9% | 633.1% | 498.0% | 12,135.7% | 207.4% | 2,099.1% | 3,854.3% | 3,846.0% | 6,176.8% | 3,374.9% | |
| – | 556.5% | 112.8% | 114.5% | 5,074.7% | – | – | 3,435.4% | 3,154.5% | 2,633.1% | 1,944.2% | |
| – | 2,226.4% | 745.9% | 612.5% | 17,210.4% | -1,109.6% | 4,279.5% | 7,289.7% | 7,000.5% | 8,810.0% | 5,315.1% | |
| – | -2,126.4% | -645.9% | -512.5% | -17,210.4% | 1,203.0% | -4,179.5% | -7,189.7% | -6,900.5% | -8,710.0% | -5,219.1% | |
| – | – | – | – | 207.9% | 20.9% | 602.6% | – | – | – | – | |
| – | -2,087.2% | -634.6% | -483.5% | -16,637.2% | -1,218.6% | -4,700.3% | -7,113.6% | -6,573.6% | -7,944.7% | -4,689.8% | |
| – | – | -0.2% | – | -731.2% | -1.2% | 48.1% | 2.7% | – | 0.8% | 0.7% | |
| – | -2,087.2% | -634.6% | -483.5% | -15,906.1% | -1,217.4% | -7,876.4% | -4,865.8% | -6,710.4% | -7,950.9% | -4,646.1% | |
| – | -2,125.8% | -645.9% | -512.5% | -21,237.7% | -1,196.1% | -4,086.0% | -7,098.5% | -6,573.6% | -7,943.9% | -4,689.8% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.